Bone Marrow Derived Mesenchymal Stromal Cells from Sickle Cell Disease Patients Display Intact Functionality

Hematopoietic cell transplantation (HCT) is the only cure for sickle cell disease (SCD), but engraftment remains challenging in patients lacking matched donors. Infusion of mesenchymal stromal cells (MSCs) at time of HCT may promote hematopoiesis and ameliorate graft-versus-host disease. Experimenta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Stenger, Elizabeth O., Chinnadurai, Raghavan, Yuan, Shala, Garcia, Marco, Arafat, Dalia, Gibson, Greg, Krishnamurti, Lakshmanan, Galipeau, Jacques
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5390328/
https://ncbi.nlm.nih.gov/pubmed/28132869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.01.081
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares